Acessibilidade / Reportar erro

Pituitary metastasis from adenocarcinoma

Metástase Hipofisária de adenocarcinoma

LETTERS

Pituitary metastasis from adenocarcinoma

Metástase Hipofisária de adenocarcinoma

Carolina Garcia Soares Leães; Luiza A.D. Silva; Júlia Fernanda Semmelmann Pereira-Lima; Jorge Kramer; Miriam da Costa Oliveira

Neuroendocrinology Center of Santa Casa de Porto Alegre, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil

Correspondence Correspondence: Carolina Garcia Soares Leães Rua Faria Santos, 142 90670-150 Porto Alegre RS - Brasil E-mail: dracarolina@cisa.med.br

Metastatic tumors of the pituitary gland are very rare, representing only 1% of the pituitary mass submitted to surgeries, and are frequently related to primary neoplasia of breast and lung1,2.

CASE

A 50-year-old male patient sought medical care complaining of cephalalgia for 4 months, diplopia and ptosis of the left eyelid for 30 days. He reported loss of libido and erectile dysfunction in the previous six months. He was before a salutary individual. Physical examination: body mass index (BMI) 24, with ptosis and ophthalmoplegia of the left eye, arterial pressure of 140/80 mmHg. No other alterations.

Magnetic resonance imaging (Figure) showed heterogeneous mass into the sella turcica with suprasellar extension, causing displacement of optic chiasm and third ventricle floor, with intense opacification after contrast.


The laboratory exams showed normal thyroid function, low levels of gonadotropins and total testosterone, normal levels of basal cortisol and IGF-1 and very small increase in serum prolactin. Renal function, serum sodium and urine density were within normal limits. Central hypogonadism and slight hyperprolactinemia were detected, without evidence of posterior pituitary alteration.

An endoscopic transsphenoidal pituitary surgery were performed and anatomopathological exam showed metastasis of moderately differentiated adenocarcinoma of unknown primary site. Postoperative exams showed anemia, increased GGt, FA and CA 19-9. Immunohistochemical analysis indicated origin in the gastrointestinal tract, imaging of thorax and abdomen showed lymphadenopathies and small irregularities on the antral mucosa wall of the stomach. Upper gastrointestinal endoscopy with biopsy showed stomach antral adenocarcinoma.

DISCUSSION

Metastatic tumors of the pituitary gland are rare complications1 that occur between 1 and 3.6% of the patients with malign tumors2 and represent between 0.14 and 28.1% of the brain metastases3.

The metastasis reported here is from a gastric adenocarcinoma. In literature, the primary neoplasias more commonly associated with pituitary metastases are breast and lung cancer, corresponding to 30-47% and 19-30% of all cases, respectively. Other sites were reported with lower frequency1-5.

The patient in question had no previous malignant history, in agreement with literature data which state that metastases may be the first manifestation of a malign tumor1,2. Pituitary metastases are symptomatic in only 7% of the cases1,2, with predominance of Diabetes insipidus (DI)3-5. This is an important characteristics in the differential diagnosis of invasive sellar lesions, as DI occurs in less than 1% of non-functioning pituitary adenomas in the first manifestation2. The patient in question did not present any clinical and laboratorial evidence of DI.

Pituitary metastases may have symptoms caused by the tumor mass, such as anterior pituitary dysfunctions, visual field alterations, cephalalgia and ophthalmoplegia1-4, the last two present in this patient. The association of ophthalmoplegia and cephalalgia is described as a sign of probable metastasis5.

Pituitary metastases are rare, but should be included in the differential diagnosis of invasive sellar lesions, especially if associated with ophthalmoplegia, ptosis and DI.

Conflitcs of interest:

The authors report no conflict of interest

Received 23 May 2011

Received in final form 28 June 2011

Accepted 6 July 2011

  • 1. Komninos J, Vlassopoulou V, Protopapa D, et al. Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 2004;89:574-580.
  • 2. Fassett DR, Couldwell WT. Metastases to the pituitary gland. Neurosurg Focus 2004;16:E8.
  • 3. Hoellig A, Niehusmann P, Flacke S, Kristof RA. Metastasis to pituitary adenoma: case report and review of the literature. Cen Eur Neurosurg 2009; 70:149-153.
  • 4. Bhatoe HS, Badwal S, Dutta V, Kannan N. Pituitary metastasis from medullary carcinoma of thyroid: case report and review of literature. J Neurooncol 2008;89:63-67.
  • 5. Morita A, Meyer FB, Laws ER Jr. Symptomatic pituitary metastases. J Neurosurg 1998;89:69-73.
  • Correspondence:

    Carolina Garcia Soares Leães
    Rua Faria Santos, 142
    90670-150 Porto Alegre RS - Brasil
    E-mail:
  • Publication Dates

    • Publication in this collection
      27 Oct 2011
    • Date of issue
      Oct 2011
    Academia Brasileira de Neurologia - ABNEURO R. Vergueiro, 1353 sl.1404 - Ed. Top Towers Offices Torre Norte, 04101-000 São Paulo SP Brazil, Tel.: +55 11 5084-9463 | +55 11 5083-3876 - São Paulo - SP - Brazil
    E-mail: revista.arquivos@abneuro.org